Skip to search formSkip to main contentSkip to account menu

suxibuzone

Known as: 1,2-diphenyl-4-n-butyl-4-hydroxymethyl-3,5-dioxopyrazolidine hemisuccinate, 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Eighteen mature, healthy horses were divided into three groups (six per group) receiving either no treatment, 15 consecutive days… 
2009
2009
REASONS FOR PERFORMING STUDY In horses, it has been demonstrated that suxibuzone (SBZ) has a lower gastric ulcerogenic effect… 
Highly Cited
2001
Highly Cited
2001
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used as analgesic and anti-rheumatic drugs, and they are often misused… 
1999
1999
Suxibuzone (SBZ), a nonsteroidal anti-inflammatory drug, was administered to 6 horses at a dose rate of 7.5 mg/kg bwt by… 
1999
1999
A disposition and bioequivalence study with a suxibuzone granulated and a suxibuzone paste oral formulation was performed in… 
1993
1993
A high performance liquid chromatographic method is described to determine the anti-inflammatory drug suxibuzone (SXB) and its… 
1982
1982
The absorption, excretion, and metabolism of a single oral dose of suxibuzone, a new nonsteroidal anti-inflammatory agent, in… 
1980
1980
A high-performance liquid chromatographic method is described for the simultaneous determination of the anti-inflammatory agent…